Inhibrx Biosciences, Inc.
INBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,687,572 | -$239,727 | -$145,226 | -$81,768 |
| Dep. & Amort. | $2,285 | $1,191 | $1,225 | $1,195 |
| Deferred Tax | $0 | $0 | $0 | -$9 |
| Stock-Based Comp. | $58,518 | $24,846 | $20,450 | $15,048 |
| Change in WC | $52,051 | $15,348 | $3,162 | -$17,516 |
| Other Non-Cash | -$1,994,835 | $5,033 | $5,088 | $2,727 |
| Operating Cash Flow | -$194,409 | -$193,309 | -$115,301 | -$80,323 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,597 | -$4,593 | -$686 | -$864 |
| Net Acquisitions | $0 | $0 | $0 | $55 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,597 | -$4,593 | -$686 | -$809 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $71,678 | $201,961 | $129,738 | $40,203 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $128,813 | $83,769 |
| Financing Cash Flow | $71,678 | $201,961 | $258,551 | $83,769 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$125,328 | $4,059 | $142,564 | $2,637 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $277,924 | $273,865 | $131,301 | $128,664 |
| End Cash | $152,596 | $277,924 | $273,865 | $131,301 |
| Free Cash Flow | -$197,006 | -$197,902 | -$115,987 | -$81,187 |